Spotify Technology S.A. (0SPT)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 496.50 |
|---|---|
| 52-week range | 344.95 – 596.70 |
| Return, 1 month / 3 months | +10.1% / +14.3% |
| Return, 1 year / 3 years | −11.7% / +225.8% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 45.7% |
| Worst drawdown (1 year) | -37.6% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Spotify Technology S.A. runs a digital audio streaming service that gives listeners access to music, podcasts and audiobooks over the internet. Its customers are everyday listeners, who can use an advertising-supported free tier or pay for a subscription that removes ads and adds features, and the company also serves advertisers and creators. The business is based in Stockholm, Sweden, and operates in many countries around the world, paying royalties to artists and rights holders for the content it streams.
The shares are listed on the London Stock Exchange in UK under the code 0SPT, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Spotify Technology S.A. (0SPT) trades on the London Stock Exchange in UK. It last closed at EUR 496.50 on 27 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,176 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.7% and over the last three months it rose 14.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.5% | ||
| From 52-week high | -14.2% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 14.3% | ||
| 6-month return | 13.6% | ||
| 12-month return, skipping the last month | -19.8% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.6% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.4% |
|---|---|
| 1 month | +10.1% |
| 3 months | +14.3% |
| 6 months | +13.6% |
| 1 year | −11.7% |
| 3 years | +225.8% |
| 5 years | +121.3% |
Signals
| 50-day / 200-day average | 463.65 / 429.89 |
|---|---|
| Golden / death cross (60 days) | Golden, 38 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 16.09 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.